The aim of the collaborations was to integrate complementary competences with joint translational research projects, increasing their critical mass and potential for success. Also, creating networks that generate competitive research financing is crucial.
Ri.MED focuses on the continuous development of its network of scientific collaborations and scientific agreements with bodies and institutions in its areas of interest. There are currently 31 ongoing agreements to develop technological innovation, promote research activities and share laboratory spaces and resources with European and U.S. institutions. Twelve agreements were signed in 2020.
Ri.MED signed agreements for lab hosting and has being managing four laboratories for several years: the Regenerative Medicine and Immunology Laboratory at IRCCS ISMETT, of strategic importance for integrating basic and clinical research; the Structural Biology and Biophysics Laboratory at ATeN Center; the Bioengineering and Medical Devices Laboratory at the University of Palermo;, and the High Throughput Screening Laboratory at the CNR IRIB.